Federal health officials have broadened their warning to doctors about other medicines made by a Massachusetts-based specialty pharmacy linked to the national meningitis outbreak.
The Food and Drug Administration took the step because of reports of new illnesses that may be tied to other products made by the New England Compounding Center of Framingham, Mass.
Now health officials want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.
A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15 and sickened more than 200 in 17 states.
The new reports include meningitis in a patient who received another steroid from NECC and fungal infections in two heart transplant patients.
